Yıl: 2021 Cilt: 30 Sayı: 4 Sayfa Aralığı: 318 - 321 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.202 1.21017 İndeks Tarihi: 06-01-2022

Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature

Öz:
Low-molecular-weight heparins, particularly enoxaparin, are widely used for pulmonary embolism prophylaxis in hospitalized patients. Although rare, bleeding has been reported due to these drugs. Because of their excretion from the kidney, the risk of bleeding is higher in the kidney patient population, and these patients should be careful, and dose adjustment should be made. This article reports 2 cases of bleeding due to enoxaparin in 2 different kidney patients who then required transfusion, the literature on this topic has been reviewed.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Quader MA, Stump LS, Sumpio BE. Low molecular weight heparins: current use and indications. J Am Coll Surg. 1998;187(6):641- 658. [CrossRef]
  • 2. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta-analysis of randomized, controlled trials. Ann Intern Med. 2004;140(3):175-183. [CrossRef]
  • 3. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and lowmolecular- weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(1):64S- 94S. [CrossRef]
  • 4. Bazinet A, Almanric K, Brunet C, et al. Dosage of enoxaparin among obese and renal impairment patients. Thromb Res. 2005;116(1):41-50. [CrossRef]
  • 5. Harenberg J. Is laboratory monitoring of low‐molecular‐weight heparin therapy necessary? Yes. J Thromb Haemost. 2004;2(4):547- 550. [CrossRef]
  • 6. Nagge J, Crowther M, Hirsh J. Is impaired renal function a contraindication to the use of low-molecular-weight heparin? Arch Intern Med. 2002;162(22):2605-2609. [CrossRef]
  • 7. Becker RC, Spencer FA, Gibson M, et al. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J. 2002;143(5):753-759. [CrossRef]
  • 8. Melde SL. Enoxaparin-induced retroperitoneal hematoma. Ann Pharmacother. 2003;37(6):822-824. [CrossRef]
  • 9. Karabulut Z, Doğan T, Aşık M, et al. Enoksaparin ilişkili spontan retroperitoneal hematom. Turk Klin Cardiovasc Sci. 2007;19(3):186-189.
  • 10. Solak Y, Atalay H, Polat I, Yeksan M. Enoxaparine-related internal oblique muscle hematoma in a patient with renal insufficiency. Turk Neph Dial Transpl. 2010;19(3):218-220. [CrossRef]
  • 11. Sunar H, Yanartaş M, Taş S. Rectus sheath hematoma due to clopidogrel and enoxaparin. Kosuyolu Kalp Derg. 2013;16(3):251-252. [CrossRef]
  • 12. Malik A, Capling R, Bastani B. Enoxaparin‐associated retroperitoneal bleeding in two patients with renal insufficiency. Pharmacotherapy. 2005;25(5):769-772. [CrossRef]
  • 13. Shokri SS, Hayati F, Ali AA, et al. Enoxaparin-associated spontaneous breast haematoma in elderly with chronic kidney disease: A case report. Gazi Med J. 2017;28(3).
  • 14. Egger SS, Sawatzki MG, Drewe J, Krähenbühl S. Life‐threatening hemorrhage after dalteparin therapy in a patient with impaired renal function. Pharmacotherapy. 2005;25(6):881-885. [CrossRef]
  • 15. Chan-Tack KM. Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin. South Med J. 2003;96(1):58-60. [CrossRef]
APA öztürk i, Şimşir M, Erken E, Altunoren O, Gungor O (2021). Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. , 318 - 321. 10.5152/turkjnephrol.202 1.21017
Chicago öztürk ilyas,Şimşir Melis,Erken Ertugrul,Altunoren Orcun,Gungor Ozkan Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. (2021): 318 - 321. 10.5152/turkjnephrol.202 1.21017
MLA öztürk ilyas,Şimşir Melis,Erken Ertugrul,Altunoren Orcun,Gungor Ozkan Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. , 2021, ss.318 - 321. 10.5152/turkjnephrol.202 1.21017
AMA öztürk i,Şimşir M,Erken E,Altunoren O,Gungor O Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. . 2021; 318 - 321. 10.5152/turkjnephrol.202 1.21017
Vancouver öztürk i,Şimşir M,Erken E,Altunoren O,Gungor O Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. . 2021; 318 - 321. 10.5152/turkjnephrol.202 1.21017
IEEE öztürk i,Şimşir M,Erken E,Altunoren O,Gungor O "Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature." , ss.318 - 321, 2021. 10.5152/turkjnephrol.202 1.21017
ISNAD öztürk, ilyas vd. "Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature". (2021), 318-321. https://doi.org/10.5152/turkjnephrol.202 1.21017
APA öztürk i, Şimşir M, Erken E, Altunoren O, Gungor O (2021). Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. Turkish journal of nephrology (Online), 30(4), 318 - 321. 10.5152/turkjnephrol.202 1.21017
Chicago öztürk ilyas,Şimşir Melis,Erken Ertugrul,Altunoren Orcun,Gungor Ozkan Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. Turkish journal of nephrology (Online) 30, no.4 (2021): 318 - 321. 10.5152/turkjnephrol.202 1.21017
MLA öztürk ilyas,Şimşir Melis,Erken Ertugrul,Altunoren Orcun,Gungor Ozkan Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. Turkish journal of nephrology (Online), vol.30, no.4, 2021, ss.318 - 321. 10.5152/turkjnephrol.202 1.21017
AMA öztürk i,Şimşir M,Erken E,Altunoren O,Gungor O Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. Turkish journal of nephrology (Online). 2021; 30(4): 318 - 321. 10.5152/turkjnephrol.202 1.21017
Vancouver öztürk i,Şimşir M,Erken E,Altunoren O,Gungor O Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature. Turkish journal of nephrology (Online). 2021; 30(4): 318 - 321. 10.5152/turkjnephrol.202 1.21017
IEEE öztürk i,Şimşir M,Erken E,Altunoren O,Gungor O "Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature." Turkish journal of nephrology (Online), 30, ss.318 - 321, 2021. 10.5152/turkjnephrol.202 1.21017
ISNAD öztürk, ilyas vd. "Bleeding After the Use of Enoxaparin in Kidney Patients: Case Reports and Review of the Literature". Turkish journal of nephrology (Online) 30/4 (2021), 318-321. https://doi.org/10.5152/turkjnephrol.202 1.21017